Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

The spectrum of behaviors influenced by serotonin.

Lucki I.

Biol Psychiatry. 1998 Aug 1;44(3):151-62. Review.

PMID:
9693387
2.

New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders.

Gingrich JA, Ansorge MS, Merker R, Weisstaub N, Zhou M.

CNS Spectr. 2003 Aug;8(8):572-7. Review.

PMID:
12907920
3.

Multiple serotonin receptors: clinical and experimental aspects.

Roth BL.

Ann Clin Psychiatry. 1994 Jun;6(2):67-78. Review.

PMID:
7804391
4.

Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).

Santarelli L, Gobbi G, Blier P, Hen R.

J Clin Psychiatry. 2002;63 Suppl 11:11-7. Review.

5.

The effects of serotonin manipulations on emotional information processing and mood.

Merens W, Willem Van der Does AJ, Spinhoven P.

J Affect Disord. 2007 Nov;103(1-3):43-62. Review.

PMID:
17363069
6.

Role of brain norepinephrine in the behavioral response to stress.

Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1214-24. Review.

PMID:
16226365
7.

Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.

Miczek KA, Fish EW, De Bold JF, De Almeida RM.

Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58. Review.

PMID:
12373445
8.

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.

Cryan JF, Valentino RJ, Lucki I.

Neurosci Biobehav Rev. 2005;29(4-5):547-69. Review.

PMID:
15893822
9.

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.

Ressler KJ, Nemeroff CB.

Depress Anxiety. 2000;12 Suppl 1:2-19. Review.

PMID:
11098410
10.

Behavioral consequences of antidepressant treatment in rodents.

File SE, Tucker JC.

Neurosci Biobehav Rev. 1986 Summer;10(2):123-34. Review.

PMID:
3526203
11.

Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Korff S, Harvey BH.

Psychiatr Clin North Am. 2006 Jun;29(2):371-90. Review.

PMID:
16650714
12.

5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.

de Boer SF, Koolhaas JM.

Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. Review.

PMID:
16310183
13.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Review.

PMID:
18761360
14.
15.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
16.

Modulation of anxiety circuits by serotonergic systems.

Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A.

Stress. 2005 Dec;8(4):233-46. Review.

PMID:
16423712
17.

Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.

Bolaños CA, Willey MD, Maffeo ML, Powers KD, Kinka DW, Grausam KB, Henderson RP.

Biol Psychiatry. 2008 Feb 1;63(3):309-16.

PMID:
17884021
18.
19.

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.

Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I.

Psychopharmacology (Berl). 1999 Nov;147(2):162-7.

PMID:
10591883
20.

Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.

Dremencov E, Weizmann Y, Kinor N, Gispan-Herman I, Yadid G.

Curr Drug Targets. 2006 Feb;7(2):165-75. Review.

PMID:
16475958
Items per page

Supplemental Content

Support Center